# Evolution of Lung 18FDG Uptake in Patients With Idiopathic Pulmonary Fibrosis and Receiving Pirfenidone

> **NCT03692481** · NA · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 50 (estimated)

## Conditions studied

- Idiopathic Pulmonary Fibrosis

## Interventions

- **RADIATION:** 18FDG-PET scan

## Key facts

- **NCT ID:** NCT03692481
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-04
- **Primary completion:** 2023-02
- **Final completion:** 2024-04
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03692481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03692481, "Evolution of Lung 18FDG Uptake in Patients With Idiopathic Pulmonary Fibrosis and Receiving Pirfenidone". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT03692481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*